276 related articles for article (PubMed ID: 15840099)
1. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
[TBL] [Abstract][Full Text] [Related]
2. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum VEGF in melanoma patients: a pilot study.
Ascierto PA; Leonardi E; Ottaiano A; Napolitano M; Scala S; Castello G
Anticancer Res; 2004; 24(6):4255-8. PubMed ID: 15736481
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression.
Gorski DH; Leal AD; Goydos JS
J Am Coll Surg; 2003 Sep; 197(3):408-18. PubMed ID: 12946796
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.
Qian CN; Zhang CQ; Guo X; Hong MH; Cao SM; Mai WY; Min HQ; Zeng YX
Cancer; 2000 Jan; 88(2):255-61. PubMed ID: 10640954
[TBL] [Abstract][Full Text] [Related]
6. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
[TBL] [Abstract][Full Text] [Related]
7. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.
Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M
Anticancer Res; 2007; 27(5A):3211-7. PubMed ID: 17970063
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.
Hofmann MA; Gussmann F; Fritsche A; Biesold S; Schicke B; Küchler I; Voit C; Trefzer U
Melanoma Res; 2009 Feb; 19(1):17-23. PubMed ID: 19104451
[TBL] [Abstract][Full Text] [Related]
9. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
George DJ; Regan MM; Oh WK; Tay MH; Manola J; Decalo N; Duggan S; Dewolf WC; Kantoff PW; Bubley GJ
Urology; 2004 Feb; 63(2):327-32. PubMed ID: 14972483
[TBL] [Abstract][Full Text] [Related]
11. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
12. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage].
Ługowska I; Kowalska M; Zdzienicki M; Fuksiewicz M; Kamińska J; Szamotulska K; Rutkowski P
Pol Merkur Lekarski; 2012 Jan; 32(187):22-7. PubMed ID: 22400175
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
15. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
18. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
Redondo P; Lloret P; Idoate M; Inoges S
Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Depasquale I; Thompson WD
Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
[TBL] [Abstract][Full Text] [Related]
20. [Serum S100B protein and stage of cutaneous melanoma: a prospective study].
Brouard M; Quillien V; Ollivier I; Lesimple T; Adamski H; Chevrant-Breton J
Ann Dermatol Venereol; 2000 Jan; 127(1):56-9. PubMed ID: 10717564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]